Literature DB >> 15670517

Frequency of factor V leiden mutation.

Masood Anwar, Suhaib Ahmed, Muhammad Ayyub, Waqar Ali.   

Abstract

OBJECTIVE: To determine the frequency of factor V leiden mutation.
DESIGN: Observational study. PLACE AND DURATION OF STUDY: One-year, January 2001 to December 2001 at the Armed Forces Institute of Pathology, Rawalpindi, Pakistan. PATIENTS AND METHODS: Two hundred subjects each of apparently healthy and unrelated Punjabi and Pathan origins were included in the study. Peripheral blood samples were collected in EDTA and DNA extracted by phenol-chloroform extraction method. DNA analysis was done by PCR for restriction fragment length polymorphism. The product was digested overnight with Mn/1 and electrophoresed on acrylamide gel to detect 67 and 153 base pair fragments of factor V leiden against 37, 67 and 116 base pair fragments of normal factor V.
RESULTS: In the 400 subjects studied, only 5 cases of heterozygotes for factor V leiden were detected. The overall carrier rate was 1.3% (95% Cl 0.2-2.2%). The carrier rate in Punjabis and Pathans was 1% and 1.5% respectively.
CONCLUSION: This study confirms that the prevalence of factor V leiden is low in Asians and Africans as compared to the European population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670517     DOI: 01.2005/JCPSP.1517

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  5 in total

1.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

2.  Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults.

Authors:  Ehsan Kheradmand; Meraj Pourhossein; Gilda Amini; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2014-02-28

3.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

4.  High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident.

Authors:  Nadir Ali; Muhammad Ayyub; Saleem Ahmed Khan
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

5.  To determine the frequency of Factor V Leiden in cases of Deep Vein Thrombosis and Healthy controls.

Authors:  Anjum Saeed; Muhammad Ali Kashif
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.